secwatch.observer — SEC 8-K summary
======================================

Issuer:     CERO THERAPEUTICS HOLDINGS, INC. (CERO)
CIK:        0001870404
Form:       8-K
Filed at:   2024-10-11T23:59:59+00:00
Accession:  0001213900-24-087267
Event type: other_material
Sentiment:  negative
Materiality: 0.60
Item codes: 2.02, 5.02, 7.01
LLM model:  deepseek-v4-flash:cloud@v2

CERo Therapeutics reports $3.3M preliminary cash; appoints Shami Patel to board
-------------------------------------------------------------------------------

- Preliminary unaudited cash and cash equivalents as of Sept 30, 2024 were approximately $3.3 million.
- Board appointed Shami Patel as Class III director effective Oct 11, 2024, filling vacancy from Dr. Corey's resignation.
- Cash estimate is preliminary and subject to change upon completion of quarter-end close; no audit performed.
- Patel is a Managing Director at Launchpad Capital with extensive SPAC and financial services experience.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1870404/000121390024087267/0001213900-24-087267-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1870404/000121390024087267/ea0217430-8k_cero.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-087267

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer